Implications of high EVI1 expression in high-risk myelodysplastic syndromes

被引：0
|
作者：
Abedin, Sameem [1 ]
Platanias, Leonidas C. [2 ,3 ,4 ]
机构：
[1] Med Coll Wisconsin, Dept Med, Div Hematol Oncol, 9200 W Wisconsin Ave, Milwaukee, WI 53226 USA
[2] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA
[3] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA
[4] Jesse Brown VA Med Ctr, Dept Med, Chicago, IL USA
来源：
LEUKEMIA & LYMPHOMA | 2018年 / 59卷 / 12期
关键词：
PROGNOSTIC SCORING SYSTEM; ACUTE MYELOID-LEUKEMIA; MUTATIONS;
D O I：
10.1080/10428194.2018.1466297
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2765 / 2766
页数：2
相关论文
共 50 条
  • [1] Treatment of high-risk myelodysplastic syndromes
    Fenaux, Pierre
    [J]. HEMATOLOGIE, 2006, 12 : 12 - 13
  • [2] Treating high-risk myelodysplastic syndromes
    Ades, Lionel
    [J]. BULLETIN DU CANCER, 2023, 110 (11) : 1162 - 1167
  • [3] Management of high-risk myelodysplastic syndromes
    Pisani, FD
    Rainaldi, A
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2001, 40 (03) : 215 - 228
  • [4] Survivin expression in "low-risk" and "high-risk" myelodysplastic syndromes
    Gianelli, Umberto
    Fracchiolla, Nicola Stefano
    Cortelezzi, Agostino
    Pellegrini, Caterina
    Savi, Federica
    Moro, Alessia
    Grimoldi, Maria Grazia
    Deliliers, Giorgio Lambertenghi
    Coggi, Guido
    Bosari, Silvano
    [J]. ANNALS OF HEMATOLOGY, 2007, 86 (03) : 185 - 189
  • [5] Survivin expression in “low-risk” and “high-risk” myelodysplastic syndromes
    Umberto Gianelli
    Nicola Stefano Fracchiolla
    Agostino Cortelezzi
    Caterina Pellegrini
    Federica Savi
    Alessia Moro
    Maria Grazia Grimoldi
    Giorgio Lambertenghi Deliliers
    Guido Coggi
    Silvano Bosari
    [J]. Annals of Hematology, 2007, 86 : 185 - 189
  • [6] Pattern of expression and their clinical implications of the GATA family, stem cell leukemia gene, and EVI1 in leukemia and myelodysplastic syndromes
    Ohyashiki, K
    Ohyashiki, JH
    Shimamoto, T
    Toyama, K
    [J]. LEUKEMIA & LYMPHOMA, 1996, 23 (5-6) : 431 - 436
  • [7] High-risk myelodysplastic syndromes in hypomethylants failure
    Gardin, Claude
    [J]. HEMATOLOGIE, 2010, 16 : 24 - 28
  • [8] Treatment of patients with high-risk myelodysplastic syndromes
    Gattermann, Norbert
    Kuendgen, Andrea
    Germing, Ulrich
    [J]. CANCER TREATMENT REVIEWS, 2007, 33 : S64 - S68
  • [9] Histopathology in the diagnosis of high-risk myelodysplastic syndromes
    Kayano, Hidekazu
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2018, 58 (02) : 51 - 60
  • [10] EVI1 expression predicts outcome in higher-risk myelodysplastic syndrome patients
    Liu, Lin
    Wang, Jinhuan
    Jiang, Yanan
    Xie, Huan
    Tang, Xiaoqiong
    Li, Qiubai
    Wang, Huaquan
    Zou, Ping
    Miao, Zhaoyi
    Lv, Yangyang
    Wang, Haitao
    Cao, Zeng
    Zhao, Zhigang
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (12) : 2929 - 2940
12345